85-2071-99　CB2 Inverse Agonist, SR 144528 (5- (4- chloro- 3- methylphenyl)- 1- [(4- methylphenyl)methyl]- N- [(1S, 2S, 4R)- 1, 3, 3- trimethylbicyclo[2.2.1]hept- 2- yl]- 1H- pyrazole-3) 5mg　CAS No:192703-06-3　217257

特徴

• A selective inverse agonist for peripheral cannabinoid (CB2) receptors (Ki = 0.6nM and 400nM for CB2 and CB1 receptors, respectively). Has been used in studies related to control of pain initiation, suppression of inflammation, and immune activation.
• Formula:C29H34ClN3O
• Solubility:DMSO
• Primary Target:CB2 Receptor
• Primary Target Ki:0.6nM and 400nM for CB2 and CB1 receptors, respectively.
• Molar Mass:475.2
• Storage and Stability:Lyophilized powder may be stored at -20°C. Stable for 12 months at -20°C. Reconstitute with sterile buffer or dH2O. Aliquot to avoid repeated freezing and thawing. Store at -20°C. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Further dilutions can be made in assay buffer.

仕様

• Size：5mg
• Grade：Highly Purified
• Purity：~98% (HPLC)
• Form：Supplied as an off-white solid.
• Molecular Formula：C29H34ClN3O
• Molecular Weight Non Ab：475.2
• EU Commodity Code：38220090
• この商品は法規制を確認しておりません。(法規制によって販売できない場合もございます)
• 製品の仕様は予告なく変更になる場合がございます。最新仕様はメーカーホームページをご確認ください。
• CAS No ：192703-06-3

• 【試薬に関するお問合せ】
• アズワン株式会社 試薬・プロセス材料グループ
• TEL：06-6447-8641
• FAX：06-6447-8642
• E-mail：[email protected]